Index
RUT
Market Cap
371.94M
Enterprise Value
363.55M
Income
-29.83M
Sales
13.89M
Book/sh
0.26
Cash/sh
0.17
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
99
IPO
Jul 02, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
26.78
P/B
26.56
P/C
40.96
P/FCF
-
EV/EBITDA
-
EV/Sales
26.17
Quick Ratio
2.44
Current Ratio
3.35
Debt/Eq
0.05
LT Debt/Eq
0.02
Option/Short
No / Yes
EPS (ttm)
-0.62
EPS next Y
-0.45
EPS next Q
-0.15
EPS this Y
45.63%
EPS next Y
19.64%
EPS next 5Y
48.58%
EPS past 3/5Y
-48.82% -
Sales past 3/5Y
17.89% -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-51.47%
Sales Q/Q
9.89%
Insider Own
49.45%
Insider Trans
11.87%
Inst Own
9.56%
Inst Trans
11.07%
ROA
-212.19%
ROE
-335.06%
ROIC
-222.42%
Gross Margin
50.88%
Oper. Margin
-217.14%
Profit Margin
-214.74%
SMA20
5.51%
SMA50
9.97%
SMA200
10.36%
Trades
Shs Outstand
50.03M
Shs Float
26.90M
52W High
15.37 -54.52%
52W Low
4.50 55.33%
Volatility
3.26% 4.67%
ATR (14)
0.30
RSI (14)
61.12
Beta
-2.42
Rel Volume
2.04
Avg Volume
157.37K
Volume
320,246
Perf Week
7.04%
Perf Month
13.29%
Perf Quarter
5.75%
Perf Half Y
15.16%
Perf YTD
-34.61%
Perf Year
42.36%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
6.80
Price
6.99
Change %
2.79%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-28-26 Resumed
Roth Capital
Buy
$9
Jul-28-25 Initiated
The Benchmark Company
Speculative Buy
$5
Jul-28-25 Initiated
Roth Capital
Buy
$6
Oct-13-26 04:05PM
Sep-28-26 09:00AM
Sep-03-26 04:05PM
Aug-14-26 01:01AM
Aug-13-26 04:05PM
04:30PM
Loading…
Aug-03-26 04:30PM
Jul-30-26 04:05PM
Jul-23-26 06:55AM
Jul-02-26 04:05PM
May-14-26 04:05PM
Apr-30-26 04:05PM
(GlobeNewswire)
+10.62%
+5.93%
Mar-27-26 08:05AM
Mar-26-26 04:05PM
Mar-20-26 08:00AM
Mar-12-26 04:05PM
04:05PM
Loading…
Mar-09-26 04:05PM
Jan-02-26 12:10PM
Dec-29-25 04:05PM
(GlobeNewswire)
-10.99%
+6.99%
Nov-20-25 04:05PM
Nov-13-25 04:05PM
Nov-12-25 07:28AM
Nov-10-25 04:05PM
Nov-04-25 09:35AM
Nov-03-25 08:00AM
Oct-30-25 04:05PM
Oct-24-25 11:15AM
Sep-25-25 04:05PM
Aug-14-25 04:05PM
10:25AM
Jul-31-25 04:05PM
11:50AM
Loading…
Jul-03-25 11:50AM
Jul-01-25 09:08PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HARARI ELIYAHOU ET AL 10% Owner Sep 18 '26 Buy 5.69 1,757,469 9,999,999 1,396,494 Sep 23 09:01 PM Shen Ching Hang 10% Owner Sep 15 '26 Buy 5.69 878,734 4,999,996 2,926,655 Sep 18 06:14 PM HARARI ELIYAHOU ET AL 10% Owner Jul 17 '26 Buy 6.73 61,068 410,988 3,343,119 Jul 21 07:04 PM HARARI ELIYAHOU ET AL 10% Owner Jul 08 '26 Buy 6.09 81,300 495,117 3,282,051 Jul 10 08:17 PM HARARI ELIYAHOU ET AL 10% Owner Jun 26 '26 Buy 7.35 13,850 101,811 3,200,751 Jul 07 10:03 PM Imperial Joanne Carol Director Jun 30 '26 Option Exercise 7.58 2,022 15,327 3,709 Jul 01 09:22 PM Tsai Chen Lung Director Jun 30 '26 Option Exercise 7.58 2,022 15,327 4,929 Jul 01 08:19 PM Kuo Hui Ying Director Jun 30 '26 Option Exercise 7.58 2,022 15,327 15,263 Jul 01 08:18 PM King Wen-Herng Henry Director Jun 30 '26 Option Exercise 7.58 2,022 15,327 25,619 Jul 01 08:18 PM Harari Michele Director Jun 30 '26 Option Exercise 7.58 2,022 15,327 61,065 Jul 01 08:18 PM GOUW JULIA S Director Jun 30 '26 Option Exercise 7.58 2,022 15,327 4,909 Jul 01 08:17 PM Atkinson Douglas Patrick Head of Global Sales May 04 '26 Option Exercise 0.34 72,571 25,000 72,571 May 06 12:50 PM Atkinson Douglas Patrick Head of Global Sales May 05 '26 Option Exercise 0.57 34,786 19,692 107,357 May 06 12:50 PM Harari Michele Director Dec 31 '25 Option Exercise 10.69 2,887 30,862 59,043 Dec 31 05:11 PM GOUW JULIA S Director Dec 31 '25 Option Exercise 10.69 2,887 30,862 2,887 Dec 31 05:10 PM Imperial Joanne Carol Director Dec 31 '25 Option Exercise 10.69 2,887 30,862 2,887 Dec 31 05:10 PM King Wen-Herng Henry Director Dec 31 '25 Option Exercise 10.69 2,887 30,862 23,597 Dec 31 05:10 PM Kuo Hui Ying Director Dec 31 '25 Option Exercise 10.69 2,887 30,862 13,241 Dec 31 05:09 PM Tsai Chen Lung Director Dec 31 '25 Option Exercise 10.69 2,887 30,862 2,887 Dec 31 05:09 PM
CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn's disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.
Co-Founder Mr. Kang-Huai Wang
Compliance Officer Mr. David Garcia
Senior Vice President of Global Sales Mr. Douglas Atkinson
Manager of Human Resources Helen Chau
Corporate Controller Anna Krylova